Thompson Creek Metals Company Inc (USA) (TC) Metals: Tomorrow’s Monster Stock?

Stocks climbing to 10 times their original price are rare breeds. But they’re not impossible to find — especially when you have Fools for friends.

The market’s best stocks include companies that have risen dozens of times in value by taking advantage of the market’s weaknesses. These aren’t penny stocks; they’re viable companies with sound business prospects that are achieving phenomenal returns. Finding just one or two of these monstrously successful firms can help you establish a winning portfolio.

Thompson Creek Metals Company Inc (USA) (NYSE:TC)Stalking the monster
To find tomorrow’s winners, we’ve enlisted the help of the monster-trackers at Motley Fool CAPS, the 180,000-member-driven investor community where informed opinion is translated into stock ratings of one to five stars. We’ll be peering in on the picks of those who have successfully chosen stocks that doubled, tripled, or even quadrupled in price, and this week All-Star member Roach75 gives us molybdenum miner Thompson Creek Metals Company Inc (USA) (NYSE:TC) as his next monster pick. He made his mark with Atlas Energy LP (NYSE:ATLS), which rose more than 1,000% after he picked it to outperform the indexes, compared with the S&P 500′s 47% increase.

Of course, you shouldn’t jump into the breach just because an All-Star stock picker did. Just consider this as a starting point for your own research of extreme buying opportunities.

Idle hands
Molybdenum, which is used to strengthen steel, saw prices rocket from $2 a pound in 2002 to $40 a pound in 2005, but they’ve fallen back below $12 a pound today. Considering the operational issues Thompson Creek was experiencing and the low-grade ore it was producing at its Endako mine in British Columbia, the low price no longer made it economical to continue operations there, and Thompson Creek shut down activity at the mine last August. Two months later it suspended stripping activity at its eponymous moly mine in Idaho, which was preparing the mine for the next stage of production. It will continue mining operations there through next year, but if pricing hasn’t improved, it will idle the Thompson Creek mine as well.

That’s a likely outcome, as Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX) — the world’s largest molybdenum miner, with more than 3.4 billion pounds in proven and probable reserves — is modeling the metal’s price at $11 per pound for 2013.

Persistent low prices could also be a problem for General Moly, Inc. (NYSEMKT:GMO) , which is trying to get its new Mount Hope molybdenum mine in Nevada operational. It completed its permitting process late last year and has now begun the construction phase at the site, which contains 1.3 billion pounds in proven and probable reserves, 1.1 billion pounds of which is deemed recoverable.

Offsetting the low-price risk is the five-year supply agreement the General entered into with ArcelorMittal (ADR) (NYSE:MT) to purchase 6.5 million pounds of molybdenum annually at prices that are currently above the spot market. It can be extended for another 10 years as well, but the steelmaker will need to own more than 11 million shares of General Moly’s stock. Thompson Creek’s agreements for its Endako mine were typically annual supply contracts that were based on moly prices at the time of the sale.

A mulligan on Milligan
Thompson Creek achieved a milestone of its own by also gaining approval for the last permits it needed to get its Mount Milligan copper and gold mine operational. The project is on track to be commissioned by this year’s third quarter, and it will begin production by the end of the year. Once it gets going, Mount Milligan should be profitable. since the feasibility studies on it used copper at $1.60 per pound and gold at $690 an ounce. With the bronze metal trading today at $3.73 and the yellow one at $1,666, the miner should realize some healthy profits from the get-go.

Yet to get to this stage, Thompson Creek had to almost give away the store. In exchange for a total of $781.5 million in much-needed financing, the miner sold more than 52% of the output from Mount Milligan at a significant discount to gold streamer Royal Gold, Inc USA) (NASDAQ:RGLD). The $435-an-ounce price — or the market price if it’s lower  – has weighed on the stock, but with the light at the end of the tunnel on getting the project up to speed, Thompson Creek has at least diversified its asset base and will no longer be dependent upon a single commodity.

Perhaps the main risk is its debt profile. While it largely financed the project with cash through its arrangements with Royal Gold, taking on only $350 million worth of senior secured debt at 9.75% at the end of last year (and cancelling its revolver because it no longer had a need for it), with production at its moly mines constrained, Thompson Creek is in a bit of a straitjacket financially should it run into unforeseen operational problems at Mount Milligan.

The long-term outlook for molybdenum remains strong, even if near-term pricing presents problems. China and India will undoubtedly continue to invest in their infrastructure, which will necessitate greater steelmaking opportunities, causing producers to need the metal in greater amounts.

For that reason, I think investors will find Thompson Creek’s current $4 per share an attractive entry point, particularly as Mount Milligan goes live and molybdenum prices recover in the future. But let me know in the comments box below whether essentially putting all its eggs into the copper and gold mine’s basket makes the miner too risky.

The article Thompson Creek Metals: Tomorrow’s Monster Stock? originally appeared on Fool.com and is written by Rich Duprey.

Fool contributor Rich Duprey has no position in any stocks mentioned. The Motley Fool owns shares of ArcelorMittal and Freeport-McMoRan Copper & Gold.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!